Oneness Biotech (4743 TT): Worth of Attention Ahead of Upcoming Key Milestones
The company’s flagship drug Fespixon has $14 billion global market opportunity, while other late-stage pipeline entail visibility in the long-term....
488 Views
MicroPort MedBot Pre-IPO - Thoughts on Valuation
MicroPort MedBot (MM), a surgical robot company, aims to raise up to US$1bn in its Hong Kong IPO. It is a subsidiary of Microport Scientific (853...
495 Views
U.S. Equity Strategy: Opportunities in Refiners & Med Device Makers
U.S. equity markets remain resilient. Led by strength in technology and biotech, the Nasdaq hit a new all-time high yesterday. Small-cap indexes...
201 Views
U.S. Equity Strategy: Opportunities in Energy & Health Care Stocks
While defensive sectors continue to lag, one cyclical sector, Energy, has surged to the top of our relative strength rankings. Though we continue...
269 Views